Steven Sweeney

President And Chief Operating Officer at Aliada Therapeutics

Steven Sweeney is an experienced executive in the biotechnology and pharmaceutical sectors. Currently serving as President and Chief Operating Officer of Aliada Therapeutics, Sweeney previously held the positions of President and CEO at Integrity Clinical Services, LLC, and Executive Vice President of Clinical Development Operations at Third Harmonic Bio, where Sweeney also served as Senior Vice President of Clinical Development Operations. Additional experience includes a role as Entrepreneur In Residence at Atlas Venture and Vice President at Rodin Therapeutics, which was later acquired by Alkermes.

Location

Cambridge, United States

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


Aliada Therapeutics

Aliada Therapeutics is a biotechnology company developing novel therapies to treat central nervous system diseases. Its platform applies its technology to specific CNS target antibody binders and progress programs through preclinical evaluation to help medical professionals treat CNS diseases.The company was founded in 2021 and is headquarteredin Boston, Massachusetts.


Employees

11-50

Links